These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program. Anderegg TR; Sader HS; Fritsche TR; Ross JE; Jones RN Int J Antimicrob Agents; 2005 Jul; 26(1):13-21. PubMed ID: 15967640 [TBL] [Abstract][Full Text] [Related]
5. In vitro selection of mutants of Streptococcus pneumoniae resistant to macrolides and linezolid: relationship with susceptibility to penicillin G or macrolides. Carsenti-Dellamonica H; Galimand M; Vandenbos F; Pradier C; Roger PM; Dunais B; Sabah M; Mancini G; Dellamonica P J Antimicrob Chemother; 2005 Oct; 56(4):633-42. PubMed ID: 16135525 [TBL] [Abstract][Full Text] [Related]
6. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of linezolid resistance in Germany, 2001-2002. Brauers J; Kresken M; Hafner D; Shah PM; Clin Microbiol Infect; 2005 Jan; 11(1):39-46. PubMed ID: 15649302 [TBL] [Abstract][Full Text] [Related]
8. Bacteriostatic or bactericidal effect of linezolid against multiresistant Streptococcus pneumoniae. Malm A; Korona-Głowniak I; Biernasiuk A; Kalasiewicz A; Juda M New Microbiol; 2008 Jul; 31(3):363-70. PubMed ID: 18843891 [TBL] [Abstract][Full Text] [Related]
9. [Nosocomial spread of linezolid-resistant Staphylococcus hominis in two hospitals in Majorca]. Ruiz de Gopegui E; Iuliana Marinescu C; Díaz P; Socías A; Garau M; Ayestarán JI; Pareja A; Gallegos MC; Pérez JL; Oliver A Enferm Infecc Microbiol Clin; 2011 May; 29(5):339-44. PubMed ID: 21435748 [TBL] [Abstract][Full Text] [Related]
11. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008. Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683 [TBL] [Abstract][Full Text] [Related]
12. Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. Jones RN; Ross JE; Fritsche TR; Sader HS J Antimicrob Chemother; 2006 Feb; 57(2):279-87. PubMed ID: 16326811 [TBL] [Abstract][Full Text] [Related]
13. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus. Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637 [TBL] [Abstract][Full Text] [Related]
14. Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program. Ross JE; Anderegg TR; Sader HS; Fritsche TR; Jones RN Diagn Microbiol Infect Dis; 2005 May; 52(1):53-8. PubMed ID: 15878443 [TBL] [Abstract][Full Text] [Related]
15. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci. Livermore DM; Mushtaq S; Warner M; Woodford N J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418 [TBL] [Abstract][Full Text] [Related]
17. Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant. Sierra JM; Ortega M; Tarragó C; Albet C; Vila J; Terencio J; Guglietta A J Antimicrob Chemother; 2009 Nov; 64(5):990-2. PubMed ID: 19717395 [TBL] [Abstract][Full Text] [Related]
18. Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries. Jones RN; Fritsche TR; Sader HS; Ross JE Diagn Microbiol Infect Dis; 2007 Oct; 59(2):199-209. PubMed ID: 17908617 [TBL] [Abstract][Full Text] [Related]
19. Whole genome analysis of linezolid resistance in Streptococcus pneumoniae reveals resistance and compensatory mutations. Billal DS; Feng J; Leprohon P; Légaré D; Ouellette M BMC Genomics; 2011 Oct; 12():512. PubMed ID: 22004526 [TBL] [Abstract][Full Text] [Related]
20. Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study. Ross JE; Fritsche TR; Sader HS; Jones RN Int J Antimicrob Agents; 2007 Mar; 29(3):295-301. PubMed ID: 17239570 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]